Author

Giuliano Rizzardini

ospedale fatebenefratelli-sacco milano - Cited by 20,889 - medicine

Biography

He works as Director 1st Division of Infectious Diseases and Allergy “Ospedale Luigi Sacco” Milano. His area of research interests are Infectious Diseases, Medicine, Virology, HIV/AIDS, Antimicrobial therapy
Title
Cited by
Year
New challenges in human monkeypox outside Africa: A review and case report from Italy
D Mileto, A Riva, M Cutrera, D Moschese, A Mancon, L Meroni, ...Travel medicine and infectious disease 49, 102386, 2022202
91
2022
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non …
H Jaeger, ET Overton, G Richmond, G Rizzardini, JF Andrade-Villanueva, ...The Lancet HIV 8 (11), e679-e689, 2021202
45
2021
Efficacy and safety of bepirovirsen in chronic hepatitis B infection
MF Yuen, SG Lim, R Plesniak, K Tsuji, HLA Janssen, C Pojoga, A Gadano, ...New England Journal of Medicine 7 (21), 1957-1968, 2022202
38
2022
Hospitalisation for monkeypox in Milan, Italy
D Moschese, A Giacomelli, M Beltrami, G Pozza, D Mileto, S Reato, ...Travel Medicine and Infectious Disease 49, 102417, 2022202
29
2022
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022
D Moschese, G Pozza, D Mileto, A Giacomelli, M Cutrera, MV Cossu, ...Eurosurveillance 27 (36), 2200675, 2022202
29
2022
Retinal vessels modifications in acute and post-COVID-19
A Invernizzi, M Schiuma, S Parrulli, A Torre, F Zicarelli, V Colombo, ...Scientific reports 11 (1), 19373, 2021202
24
2021
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study
A Giacomelli, AL Ridolfo, L Pezzati, L Oreni, G Carrozzo, M Beltrami, ...PloS one 17 (4), e0263548, 2022202
14
2022
Natural history of human Monkeypox in individuals attending a sexual health clinic in Milan, Italy
D Moschese, G Pozza, A Giacomelli, D Mileto, MV Cossu, M Beltrami, ...Journal of Infection 86 (1), e18-e20, 2023202
12
2023
Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t) ide analogue therapy: interim results from the randomised phase …
RMF Yuen, R Plesniak, SG Lim, K Tsuji, G Diaconescu, A Gadano, ...The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, 2022202
10
2022
Is smallpox vaccination protective against human monkeypox?
D Moschese, D Farinacci, G Pozza, A Ciccullo, MV Cossu, A Giacomelli, ...Journal of Medical Virology, 2022202
10
2022
Phase IIa proof-of-concept evaluation of the antiviral efficacy, safety, tolerability, and pharmacokinetics of the next-generation maturation inhibitor GSK3640254
CD Spinner, F Felizarta, G Rizzardini, P Philibert, E Mitha, P Domingo, ...Clinical Infectious Diseases 75 (5), 786-794, 2022202
10
2022
Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination
Implementation of HCV screening in the 16–18 birth‐cohort undergoing COVID‐1 vaccinationR D’Ambrosio, G Rizzardini, M Puoti, S Fagiuoli, MP Anolli, C Gabiati, ...Liver International 42 (5), 1012-1016, 2022202
9
2022
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
D Mileto, V Micheli, C Fenizia, M Cutrera, G Gagliardi, A Mancon, ...Emerging Microbes & Infections 11 (1), 70-72, 2022202
9
2022
Brief report: impact of the COVID-19 pandemic on virological suppression in people living with HIV attending a large Italian HIV clinic
A Giacomelli, C Bonazzetti, F Conti, L Pezzati, L Oreni, V Micheli, ...Journal of Acquired Immune Deficiency Syndromes (1999) (3), 299, 2021202
8
2021
Long-acting cabotegravir+ rilpivirine every 2 months: ATLAS-2M week 152 results
ET Overton, G Richmond, G Rizzardini, A Thalme, PM Girard, A Wong, ...Conference on Retroviruses and Opportunisitic Infections, 2022202
7
2022
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving …
E Gane, V de Ledinghen, DE Dylla, G Rizzardini, ML Shiffman, ST Barclay, ...Journal of Viral Hepatitis 28 (11), 135-142, 2021202
6
2021
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry
A Giacomelli, AL Ridolfo, C Bonazzetti, L Oreni, F Conti, L Pezzati, ...BMC Infectious Diseases 22 (1), 1-10, 2022202
6
2022
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people≥ 65 …
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 9‐week, phase 3b, open‐label, switch trial in virologically suppressed people≥ 5 …F Maggiolo, G Rizzardini, JM Molina, F Pulido, S De Wit, ...HIV medicine 24 (1), 27-3, 2023202
6
2023
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
L Taramasso, P Bonfanti, E Ricci, P Maggi, G Orofino, N Squillace, ...HIV medicine 23 (1), 70-79, 2022202
6
2022
Route of monkeypox viral inoculum as a determinant of atypical clinical presentation.
A Giacomelli, D Moschese, G Pozza, G Casalini, MV Cossu, G Rizzardini, ...Journal of Medical Virology, 2022202
6
2022

Referred From: https://scholar.google.com/citations?user=2qEhS1YAAAAJ&hl=en

Cited by
Citations 20889
h-index 56
i10-index 234
Recommended Journals
Open Access Journals